The investment bank Goldman Sachs has raised its target price for the smaller biotech company MoonLake Immunotherapeutics by 32% to $82 per share, double the closing price on Friday, January 17. Promising results from studies of MoonLake’s drug for skin inflammation led Goldman Sachs to believe that it could become…
According to the World Health Organization, one in five people worldwide develops some form of cancer in their lifetime. While certain cancers respond well to treatment, others manage to “shield” themselves from targeted therapies. The micro-cap company MAIA Biotechnology is developing a drug to “trick” cancer cells, infiltrate them, and…
Shares of small-cap company Sezzle surged more than 20% early on Thursday, January 16. The fintech company runs an alternative payment platform offering buy now, pay later (BNPL) options. The driver of Thursday’s gains was the announcement by Sezzle that “exceptional holiday demand” would allow it to exceed its already-strong…
Shares of micro-cap company GeoVax, which specializes in cancer treatments and vaccines, rose nearly 7% on Wednesday, January 15. The company announced “significant progress” in early testing of its cancer drug for head and neck cancer and confirmed plans to move to the next phase of clinical trials. Analysts see…
Managers of the Royce Small-Cap Total Return Fund have revealed which holdings added the most to and subtracted the most from the portfolio’s performance in the 2024 fourth quarter and full year. Royce Investment Partners, founded by Wall Street legend Chuck Royce, generally focuses on small-cap investments, while the Royce…
Hindenburg Research, the activist short-selling firm known for triggering massive selloffs and criminal investigations with its reports, is shutting down. Founder Nate Anderson attributed the decision to stress and said he had earned enough money to focus on low-risk investments. Details Anderson announced the closure of Hindenburg Research in a…
Applied Digital, a builder of data centers, whose shares are held by AI chip market leader Nvidia, has reached an agreement for Australia-based Macquarie to invest up to $5 billion in Applied Digital’s AI data center projects. Following the news, Applied Digital stock surged almost 10% before giving back around…
Shares of H&E Equipment Services, a small-cap industrial equipment rental company, more than doubled on Tuesday, January 14, hitting a record high. The trigger was an announcement that the company would be acquired at a premium by its largest competitor, United Rentals. Analysts say this is an opportune time for…
Billionaire Bill Ackman aims to create a “modern-day Berkshire,” a reference to the investment company of Warren Buffett, using the real estate developer Howard Hughes Holdings (HHH) as the foundation. Ackman’s hedge fund, Pershing Square, has proposed acquiring additional shares of HHH at a premium and merging it with a…
Zacks Small-Cap Research (Zacks SCR) has raised its target price for Perfect Corp., a smaller company that develops AI solutions for the beauty and fashion industries, by almost 15% as it believes the company’s recent acquisition of a competitor significantly expands its capabilities. The acquired company is Wannaby, a virtual…
Quotes on Gryphon Digital Mining, which brands itself as a carbon-neutral bitcoin miner, climbed about 2% in premarket trading today, Monday, January 13, following a nearly 20% surge ahead of the weekend. These gains came after the company announced an agreement to purchase an energy site in Canada, which Gryphon…
Shares of the small-cap AtlasClear Holdings, a fintech firm developing a trading platform aimed at small- and middle-market financial services firms, plunged nearly 12% on Friday, January 10, to hit an all-time low. The trigger was the reveal of a new strategy, according to which AtlasClear said it will focus…
In an interview, Francis Gannon, co-CIO at Royce, founded by Wall Street legend Chuck Royce, has spotlighted four small-cap stocks that two Royce funds have «high long-term confidence» in. Arcosa With a market capitalization of $4.6 billion, Arcosa provides infrastructure-related products and solutions, including construction materials, engineering solutions, and transportation products.…
On January 6, 2025, Israel’s Gilat Satellite Networks, which develops, manufactures, and markets ground-based satellite systems for in-flight connectivity, completed its acquisition of U.S.-based Stellar Blu, a provider of avionics solutions and satellite communications terminals. In an exclusive interview with Kursiv.Investments, Gilat CFO Gil Benyamini explained the significance of the…
On Wednesday, January 8, shares of plant-based energy drink producer Yerbaé Brands Corp spiked more than 20% to hit a four-month high following the announcement of its acquisition by U.S.-based beverage maker Safety Shot. Meanwhile, Safety Shot stock plummeted following the news. The transaction values Yerbaé at more than $15…
The stock price of Sana Biotechnology surged 160% on January 8, with intraday gains exceeding 300%. The company announced a groundbreaking achievement: successfully transplanting insulin-producing pancreatic cells into a patient with type 1 diabetes without the need for immunosuppression. Sana hopes this breakthrough will revolutionize the nearly $100 billion diabetes…
On Tuesday, January 7, shares of small cancer drug developer MAIA Biotechnology jumped more than 15% to hit their highest level in a month and a half as investors rushed to buy MAIA shares on news of the company’s new partnership with leading Chinese pharmaceutical firm BeiGene, positioning the duo…
Shares of micro-cap Achieve Life Sciences rose 5% on Tuesday, January 7, following the company’s announcement that its clinical trial for a smoking cessation drug successfully reached a critical milestone. This progress allows Achieve to file for regulatory approval and, if granted, begin commercial sales. Details On January 7, Achieve’s…
Shares of Acurx Pharmaceuticals, a small company specializing in the development of new antibiotics, fell 10% in after-hours trading on January 6 following the announcement of a planned secondary offering. The news dampened investor enthusiasm sparked earlier that day by regulatory approval of the company’s trial plan for its lead…
Shares of Citius Oncology, a lymphoma drug developer with a market capitalization of $110 million, jumped more than 18% on Monday, January 6, following the announcement that it had hired the investment bank Jefferies as a financial advisor to explore strategic alternatives. Details On Monday, Citius Oncology stock soared more…
In December, Carl Icahn, one of Wall Street’s most successful investors, increased his stake in nitrogen fertilizer producer CVR Partners to 38% by purchasing common units worth $2.4 million. The billionaire took an interest in the company after Donald Trump‘s victory in the U.S. presidential election. Known as an activist…
The Motley Fool has highlighted three stocks that investors should keep an eye on: two large caps and one small cap. It believes that all three have the potential to double investors’ money over the next decade but might appeal more to those willing to take on higher risk. AppLovin…
Freedom Broker has highlighted three small-cap companies worth investors’ attention. While operating across different industries, these companies share one common trait: their stock has a projected growth potential of at least 20% in 2025. Strawberry Fields REIT Strawberry Fields, a real estate investment trust (REIT) named after the famous 1967…
The percentage of employees whose workplace drug test showed signs of tampering has reached a 30-year high, warns Quest Diagnostics, one of the largest independent laboratories in the U.S. To deceive employers, test-takers substitute urine specimens, use synthetic alternatives, or mix samples with additives. The micro-cap Intelligent Bio Solutions (INBS),…
